Tue, Jan 25, 2022 12:30 PM – 1:30 PM EST Presenter: Rich Gliklich, CEO, OM1 Register >> Real-World Data (RWD) and Artificial Intelligence (AI) applications are rapidly growing in importance in R&D for Chronic and Immune-mediated Diseases. Join us as we explore: Data Networks The ‘Unstructured’ Medical Record Hybrid Data Collection Data Linkage Artificial Intelligence[…]
SEPTEMBER 15, 2021 By Joseph Zabinski, PhD, Senior Director of AI & Precision Medicine, OM1 As innovation in devices and diagnostics accelerates, research approaches and outcomes programs also need to advance to support these developments with high-quality evidence. At the same time, demonstrating the effectiveness of a device can be challenging because outcomes depend highly[…]
Wed, Sep 29, 2021 11:00 AM – 12:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Real-world data (RWD) is increasingly being used to develop external control arms (ECA) for trial planning and regulatory submissions. But, what types of RWD is needed and how should it be applied to be successful? Join Dr.[…]
April 2, 2021 – Austin American-Statesman Read the Full Article >> If you had osteoarthritis in your knee, how would you know when it’s the right time to have knee replacement surgery? Dell Medical School at the University of Texas helped patients at UT Health Austin’s Musculoskeletal Institute answer that question by studying a new artificial intelligence tool[…]
BMJ Journals Published: May 20, 2021 Read the Full Manuscript >> Objective Use of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) in routine clinical practice is inconsistent, and availability of clinician-recorded SLEDAI scores in real-world datasets is limited. This study aimed to validate a machine learning model to estimate SLEDAI score categories using clinical notes[…]
